{"filing":{"accession_number":"0001493152-26-036331","cik":"0001196298","ticker":"NEPH","company_name":"NEPHROS INC","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1196298/000149315226036331/form8-k.htm"},"events":[{"id":25785,"run_id":23405,"accession_number":"0001493152-26-036331","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a press release disclosing Nephros' quarterly financial results for Q2 2026 (ended June 30, 2026), filed as Exhibit 99.1 under Item 2.02. The release reports record net revenue of $6.0 million (up 36% YoY), net income of $1.2 million, and adjusted EBITDA of $1.3 million, along with detailed financial statements and management commentary on business performance and outlook. This is a standard earnings release material to investors assessing the registrant's financial condition.","company_name":"NEPHROS INC","ticker":"NEPH","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26704,"accession_number":"0001493152-26-036331","item_number":"2.02","item_title":"have been furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a press release disclosing Nephros' quarterly financial results for Q2 2026 (ended June 30, 2026), filed as Exhibit 99.1 under Item 2.02. The release reports record net revenue of $6.0 million (up 36% YoY), net income of $1.2 million, and adjusted EBITDA of $1.3 million, along with detailed financial statements and management commentary on business performance and outlook. This is a standard earnings release material to investors assessing the registrant's financial condition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:33:46.001694+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26704,"accession_number":"0001493152-26-036331","item_number":"2.02","item_title":"have been furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a press release disclosing Nephros' quarterly financial results for Q2 2026 (ended June 30, 2026), filed as Exhibit 99.1 under Item 2.02. The release reports record net revenue of $6.0 million (up 36% YoY), net income of $1.2 million, and adjusted EBITDA of $1.3 million, along with detailed financial statements and management commentary on business performance and outlook. This is a standard earnings release material to investors assessing the registrant's financial condition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:33:46.001694+00:00","company_name":"NEPHROS INC","ticker":"NEPH","filing_date":"2026-08-06"}]}